Ketoconazole and Warfarin Interaction

Mechanism of Interaction

Ketoconazole is a strong P-glycoprotein inhibitor that markedly increases exposure to anticoagulants and is contraindicated with certain oral anticoagulants due to dramatically elevated bleeding risk 1
Ketoconazole inhibits CYP2C9, the primary enzyme responsible for metabolizing the S-enantiomer of warfarin, leading to increased warfarin plasma concentrations and enhanced anticoagulant effects 2
Very large increases in drug exposure caused by ketoconazole are likely to raise the bleeding risk significantly 1

Consider a pre-emptive warfarin dose reduction of 25-33% when initiating ketoconazole therapy 2
Monitor INR closely whenever ketoconazole is initiated, as all drug interactions affecting warfarin require careful INR monitoring 2
The risk of major bleeding is significantly elevated when warfarin is combined with drugs that inhibit its metabolism 3

Enzyme inducers, such as griseofulvin, carbamazepine, and phenobarbitone, induce cytochrome P450 enzymes, which accelerate warfarin metabolism and reduce its anticoagulant effect 2
Enzyme inducers require higher warfarin doses during treatment to maintain therapeutic anticoagulation 2
The full effect of enzyme induction takes 2-4 weeks to develop and persists for 2-4 weeks after discontinuation 2

The American College of Cardiology notes that concomitant medications, such as NSAIDs, can double the risk of bleeding versus warfarin alone through both pharmacokinetic interactions and direct antiplatelet effects 4
The American College of Cardiology recommends considering patient-specific risk factors for hemorrhage, including history of gastrointestinal bleeding or stroke, renal insufficiency or anemia, and INR >3.0-3.5, which substantially increases intracranial hemorrhage risk 5

Aspirin and antiplatelet agents impair platelet function and produce gastric erosions, according to the American College of Cardiology 5
SSRIs more than double bleeding risk compared to warfarin alone, as reported in Circulation: Arrhythmia and Electrophysiology 4
The American College of Cardiology states that INR >3.0-3.5 substantially increases intracranial hemorrhage risk, with a significant increase in major bleeding from 1.7% to 4.2% per year 5, 6